journal article·2014-06

Influence of Mg doping level on morphology, optical, electrical properties and antibacterial activity of ZnO nanostructures

Javed Iqbal, Tariq Jan, Muhammad Ismail, Naeem Ahmad, Asim Arif, Mohsin Khan, M. Adil, Sami-ul-Haq, Aqsa Arshad

Ceramics International· Volume 40· Issue 5
Publisher page

Abstract

Abstract Despite multiple research approaches, bacterial contamination and related infections are still serious issues in health care, which demand advance antibacterial agents. In this context, ZnO nanomaterial is of special interest due to its significant antibacterial activity and non toxic nature towards healthy cells. However, its antibacterial activity needs to be enhanced for various applications. Here, we report the antibacterial activity of Mg doped ZnO nanostructures towards Staphylococcus aureus (S. aureus) and Pseudomonas aeruginosa bacteria. It is found from antibacterial assay that all the synthesized nanostructures inhibit almost 90% growth rate of both bacterial strains. In vitro test clearly suggests that prepared nanostructures show antibacterial activity towards both bacterial strains. In case of S. aureus, undoped and Mg doped ZnO nanostructures produce same zone of inhibition (ZOI) i.e. 10 mm. However, in presence of undoped ZnO, bacterial strain shows quick re-growth. Interestingly, the re-growth initially slows down with the increase in Mg doping level and then vanishes in presence of 10% Mg doped ZnO nanostructures.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: ZnO doping and properties · Ga2O3 and related materials · Nanoparticles: synthesis and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (34)

Show source-provided references
1. Emerging and re-emerging infectious diseases10.1053/jinf.1999.0624 ↗
2. Antibacterial activity of metal oxide nanoparticles against gram-positive and gram-negative bacteria: a comparative study
3. Community acquired methicillin- resistant Staphylococcus aureus carrying Panton–Valentine leukocidin genes10.3201/eid0908.030089 ↗
4. Bacterial biofilms: from the natural environment to infectious diseases10.1038/nrmicro821 ↗
5. Photocatalytic antibacterial performance of Sn4+-doped TiO2 thin films on glass substrate10.1016/j.jhazmat.2008.06.043 ↗
6. Probing interaction of gram-positive and gram-negative bacterial cells with ZnO nanorods10.1016/j.msec.2012.12.019 ↗
7. Cu and CuO nanoparticles immobilized by silica thin films as antibacterial materials and photocatalysts10.1016/j.surfcoat.2010.06.036 ↗
8. The structural analysis of biomacromolecule wool fiber with Ag-loading SiO2 nano antibacterial agent by UV radiation10.1016/j.jphotochem.2006.11.025 ↗
9. Photocatalytic and bactericidal activities of hydrothermally and sonochemically prepared Fe2O3–SnO2 nanoparticles10.1016/j.mssp.2012.12.030 ↗
10. Quantitative evaluation of antifungal activity of metallic oxide powders (MgO, CaO and ZnO) by an indirect conductimetric assay10.1111/j.1365-2672.2004.02234.x ↗
11. Surface modification of ZnO nanocrystals10.1016/j.apsusc.2006.12.091 ↗
12. Zinc oxide nanoparticles as selective killers of proliferating cells
13. Size-dependent bacterial growth inhibition and mechanism of antibacterial activity of zinc oxide nanoparticles10.1021/la104825u ↗
14. Antibacterial activity of ZnO nanoparticle suspensions on a broad spectrum of microorganisms10.1111/j.1574-6968.2007.01012.x ↗
15. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties
16. Enhancement of green emission from Sn-doped ZnO nanowires10.1016/j.optmat.2010.08.029 ↗
17. Stabilization of intrinsic defects at high temperatures in ZnO nanoparticles by Ag modification10.1016/j.jcis.2011.09.065 ↗
18. Comparative studies on influence of morphology and La doping structural, optical and photocatalytic properties ZnO nanostructures10.1016/j.jcis.2013.06.004 ↗
19. Sn doping induced enhancement in the activity of ZnO nanostructures against antibiotic resistant S. aureus bacteria10.2147/IJN.S45439 ↗
20. Structural, optical, photo catalytic and antibacterial activity of ZnO and Co doped ZnO nanoparticles10.1016/j.matlet.2011.03.079 ↗
21. Synthesis, characterization and antimicrobial investigation of mechanochemically processed silver doped ZnO nanoparticles10.1248/cpb.c110479 ↗
22. Structure and optical properties of Mg-doped ZnO nanoparticles by polyacrylamide method10.1002/crat.201200438 ↗
23. Photocatalytic performance of novel samarium-doped spherical-like ZnO hierarchical nanostructures under visible light irradiation for 2,4-dichlorophenol degradation10.1016/j.jcis.2013.03.043 ↗
24. Growth mechanisms and characteristics of ZnO nanostructures doped with In and Ga10.1143/JJAP.49.06GJ06 ↗
25. Characterization of ZnO nanopowders synthesized by the polymerized complex method via an organochemical route
26. Spectroscopic characterization of zinc oxide nanorods synthesized by solid state reaction10.1016/j.saa.2005.10.001 ↗
27. Effect of annealing temperature on the structural and optical properties of Zn1–xMgxO particles prepared by oxalate precursor10.1016/j.colsurfa.2008.01.041 ↗
28. Structural and dielectric properties of Fe doped ZnO nanoparticles10.1007/s12648-012-0182-3 ↗
29. In vitro antibacterial activity and minimum inhibitory concentration of zinc oxide and nano-particle zinc oxide against pathogenic strains
30. Antibacterial surface coatings from zinc oxide nanoparticles embedded in poly(N isopropylacrylamide) hydrogel surface layers10.1002/adfm.201102980 ↗
31. Influence of particle size on the antibacterial activity of zinc oxide10.1016/S1466-6049(01)00197-0 ↗
32. Controllable synthesis of ZnO nanoparticles and their morphology-dependent antibacterial and optical properties10.1016/j.jphotobiol.2013.01.004 ↗
33. Green synthesis of nanostructured materials for antibacterial and antifungal activities
34. Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost10.1007/s00125-010-1672-5 ↗